Savers Value Village Insiders: 3,970 & 2,100 Shares Sold Under 10b5-1

Rhea-AI Filing Summary

Insider transactions by Mark T. Walsh, CEO & Director of Savers Value Village, Inc. (SVV). On 09/17/2025 and 09/18/2025 Mr. Walsh executed exercise-type acquisitions and contemporaneous sales under a 10b5-1 plan. He acquired 3,970 shares on 09/17/2025 and 2,100 shares on 09/18/2025 at an exercise price of $1.41 per share. Matching sales were executed pursuant to a 10b5-1 plan: 3,970 shares sold on 09/17/2025 at a weighted average price of $13.0106 and 2,100 shares sold on 09/18/2025 at a weighted average price of $13.0002. The Form 4 also discloses previously granted options under the 2019 Management Incentive Plan with exercise price $1.41, exercisable and expiring 10/07/2029, and shows large numbers of underlying shares reported in the table.

Positive

• Transactions were executed pursuant to a 10b5-1 plan, which provides pre-established rules for insider sales and may mitigate concerns about selective timing.
• Options were fully vested from the October 7, 2019 grant, removing uncertainty about vesting restrictions for the exercised options.
• Weighted-average sale prices disclosed ($13.0106 and $13.0002) with an offer to provide execution-level detail on request, indicating transparency.

Negative

• Large disposals of exercised shares were sold shortly after acquisition, which may be viewed by some investors as monetization of equity rather than long-term holding.
• Form does not provide a breakdown of the number of shares sold at each specific price within the disclosed ranges without requesting additional detail.

Insights

Securities/Insider Transactions Analyst

TL;DR: CEO exercised options at $1.41 and sold shares under a 10b5-1 plan at ~ $13.00, indicating routine monetization of vested equity.

The filing documents option exercises (codes M) and contemporaneous sales executed pursuant to a 10b5-1 plan adopted May 19, 2025. The exercises occurred on 09/17/2025 (3,970 options) and 09/18/2025 (2,100 options) at the stated exercise price of $1.41, with weighted-average sale prices of $13.0106 and $13.0002 respectively. The Form confirms the October 7, 2019 option grant fully vested by October 7, 2024 and includes both time-based and performance-based components. This appears procedural and disclosed in compliance with Section 16 reporting requirements.

Corporate Governance Specialist

TL;DR: Transactions disclosed follow an established 10b5-1 plan and exercise of vested awards; disclosure is complete regarding weighted average sale prices.

The Form 4 identifies the reporting person as CEO & Director and notes the adoption date of the 10b5-1 plan. It provides weighted-average sale prices and offers to provide price-by-price execution details upon request. The filing also restates the composition of the 2019 option grant (time-based vs performance-based vesting). Documentation and signature by an attorney-in-fact are included, indicating procedural completion of the filing formalities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walsh Mark T.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & Director

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		M		3,970	A	$1.41	3,970	D
Common Stock	09/17/2025		S(1)		3,970	D	$13.0106(2)	0	D
Common Stock	09/18/2025		M		2,100	A	$1.41	2,100	D
Common Stock	09/18/2025		S(1)		2,100	D	$13.0002(3)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(4)	$1.41	09/17/2025		M			3,970	(5)	10/07/2029	Common Stock	3,970	$1.41	2,100,740(6)	D
Option (Right to Purchase)(4)	$1.41	09/18/2025		M			2,100	(5)	10/07/2029	Common Stock	2,100	$1.41	2,098,640(6)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 19, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from$13.00 to $13.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.00 to $13.005. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

4. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

5. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024.

6. Approximately 37% represents time-based options which vested in substantially equal annual installments over five years starting October 7, 2020 and approximately 63% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway, attorney in fact	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SVV insider Mark T. Walsh do on 09/17/2025 and 09/18/2025?

He exercised options to acquire 3,970 shares on 09/17/2025 and 2,100 shares on 09/18/2025 at an exercise price of $1.41, and matching sales were executed under a 10b5-1 plan.

At what prices were the SVV shares sold by the insider?

The filing reports weighted-average sale prices of $13.0106 for the 09/17/2025 sales and $13.0002 for the 09/18/2025 sales; executions occurred in price ranges noted in the Form 4.

Was the sale executed under a trading plan for SVV insider activity?

Yes. The sale was made pursuant to a 10b5-1 plan adopted May 19, 2025, as stated in the Form 4 explanation.

What options grant is related to these transactions?

The exercised options stem from the October 7, 2019 Management Incentive Plan grant with an exercise price of $1.41 and an expiration/exercisable reference of 10/07/2029; the grant vested in installments and was fully vested on October 7, 2024.

Who signed the Form 4 filing for the reporting person?

The Form 4 signature block shows the filing was executed by Richard Medway, attorney in fact on 09/19/2025.